We are live on ! Find out more
XK

Xact Kapitalforvaltning Portfolio holdings

AUM $4.7B
1-Year Est. Return 0.05%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
-0.05%
3 Year Est. Return
+34.22%
5 Year Est. Return
10 Year Est. Return
AUM
$3.49B
AUM Growth
+$200M
Cap. Flow
+$51.1M
Cap. Flow %
1.46%
Top 10 Hldgs %
19.77%
Holding
639
New
2
Increased
496
Reduced
70
Closed
15

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$11.1M
2
AAPL icon
Apple
AAPL
+$2.86M
3
META icon
Meta Platforms (Facebook)
META
+$1.99M
4
NVDA icon
NVIDIA
NVDA
+$1.98M
5
ORCL icon
Oracle
ORCL
+$1.88M

Sector Composition

Rank Sector Weight
1 Technology 18.96%
2 Financials 16.35%
3 Healthcare 16.08%
4 Communication Services 12.22%
5 Consumer Discretionary 11.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$322B
$27.9M 0.8%
456,089
+6,350
+1% +$385K
CELG
27
DELISTED
Celgene Corp
CELG
$26.7M 0.76%
183,129
-630
-0.3% -$85.8K
ABBV icon
28
AbbVie
ABBV
$443B
$26.4M 0.76%
297,475
+4,133
+1% +$315K
MA icon
29
Mastercard
MA
$502B
$25.8M 0.74%
182,499
+2,422
+1% +$321K
DD icon
30
DuPont de Nemours
DD
$18.5B
$24.4M 0.7%
139,313
+66,574
+92% +$11.1M
AMGN icon
31
Amgen
AMGN
$208B
$23.7M 0.68%
126,915
+2,096
+2% +$371K
MCD icon
32
McDonald's
MCD
$192B
$20.9M 0.6%
133,449
+1,271
+1% +$199K
IBM icon
33
IBM
IBM
$211B
$20.8M 0.6%
150,113
+1,644
+1% +$229K
MMM icon
34
3M
MMM
$90.9B
$19.5M 0.56%
110,854
+2,001
+2% +$347K
AVGO icon
35
Broadcom
AVGO
$1.85T
$19.1M 0.55%
789,220
+11,430
+1% +$283K
GILD icon
36
Gilead Sciences
GILD
$162B
$19M 0.54%
234,919
+11,635
+5% +$890K
NVDA icon
37
NVIDIA
NVDA
$4.86T
$18.5M 0.53%
4,134,520
+476,680
+13% +$1.98M
BMY icon
38
Bristol-Myers Squibb
BMY
$133B
$18.4M 0.53%
288,663
+2,238
+0.8% +$131K
MDT icon
39
Medtronic
MDT
$109B
$17.5M 0.5%
225,353
+3,300
+1% +$274K
TWX
40
DELISTED
Time Warner Inc
TWX
$17.1M 0.49%
167,376
+4,788
+3% +$486K
BKNG icon
41
Booking.com
BKNG
$149B
$17.1M 0.49%
233,800
+10,375
+5% +$787K
ACN icon
42
Accenture
ACN
$102B
$16.5M 0.47%
121,914
+44
+0% +$5.73K
LLY icon
43
Eli Lilly
LLY
$1.02T
$15.9M 0.46%
185,857
+1,448
+0.8% +$119K
CVS icon
44
CVS Health
CVS
$133B
$15.6M 0.45%
192,115
+5,818
+3% +$460K
UNP icon
45
Union Pacific
UNP
$174B
$15.6M 0.45%
134,287
+1,973
+1% +$212K
TMO icon
46
Thermo Fisher Scientific
TMO
$213B
$15.2M 0.44%
80,445
+680
+0.9% +$123K
KO icon
47
Coca-Cola
KO
$377B
$14.9M 0.43%
331,230
+10,346
+3% +$471K
GS icon
48
Goldman Sachs
GS
$300B
$14.8M 0.42%
62,516
+536
+0.9% +$121K
ABT icon
49
Abbott
ABT
$183B
$14.6M 0.42%
272,860
+5,403
+2% +$271K
BIDU icon
50
Baidu
BIDU
$37.7B
$14.2M 0.41%
57,414
+4,600
+9% +$1M

Similar funds

Xact Kapitalforvaltning's Q3 2017 Portfolio in Review

As of Q3 2017, Xact Kapitalforvaltning held 639 positions worth $3.49B, up 6.1% from $3.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.7%. Xact Kapitalforvaltning opened 2 new positions and exited 15, leaving the 639-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Xact Kapitalforvaltning's largest Q3 2017 buy was Baker Hughes: 33,662 shares worth $1.23M.
  • Xact Kapitalforvaltning added most to DuPont de Nemours in Q3 2017, an estimated $11.1M increase.
  • Xact Kapitalforvaltning's biggest Q3 2017 reduction was Atmos Energy, cutting an estimated $3.64M.
  • Xact Kapitalforvaltning fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $5.5M.
  • Xact Kapitalforvaltning's ten largest holdings make up 20% of its $3.49B portfolio in Q3 2017.
  • Xact Kapitalforvaltning opened 2 new positions and closed 15 in Q3 2017.
  • Xact Kapitalforvaltning's portfolio value rose 6.1% quarter-over-quarter to $3.49B.

Based on Xact Kapitalforvaltning's 13F filing for Q3 2017, filed 24 Oct 2017.